{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:26:14Z","timestamp":1759159574861},"reference-count":38,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ijmm.2014.04.001","type":"journal-article","created":{"date-parts":[[2014,4,19]],"date-time":"2014-04-19T20:00:35Z","timestamp":1397937635000},"page":"586-591","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany"],"prefix":"10.1016","volume":"304","author":[{"given":"Nicole Nari","family":"Horn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kresken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"K\u00f6rber-Irrgang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"G\u00f6ttig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Wichelhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Wichelhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2014.04.001_bib0005","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1128\/JCM.34.12.3214-3217.1996","article-title":"Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: investigation using 510(k) review criteria, recommended by the Food and Drug Administration","volume":"34","author":"Biedenbach","year":"1996","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0010","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/sti.2010.044586","article-title":"Azithromycin in the treatment of infection with Neisseria gonorrhoeae","volume":"86","author":"Bignell","year":"2010","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1258\/ijsa.2011.011267","article-title":"UK national guideline for the management of gonorrhoea in adults, 2011","volume":"22","author":"Bignell","year":"2011","journal-title":"Int. J. STD AIDS"},{"key":"10.1016\/j.ijmm.2014.04.001_bib0020","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMp1112456","article-title":"The emerging threat of untreatable gonococcal infection","volume":"366","author":"Bolan","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0025","first-page":"590","article-title":"Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0030","doi-asserted-by":"crossref","DOI":"10.2807\/ese.18.03.20358-en","article-title":"Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrugresistant clone","volume":"18","author":"Chisholm","year":"2013","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0035","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A8","author":"Clinical and Laboratory Standards Institute","year":"2009"},{"key":"10.1016\/j.ijmm.2014.04.001_bib0040","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/sti.2010.044164","article-title":"European surveillance of antimicrobial resistance in Neisseria gonorrhoeae","volume":"86","author":"Cole","year":"2010","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s10096-006-0134-y","article-title":"Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany","volume":"25","author":"Enders","year":"2006","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0050","series-title":"Response plan to control and manage the threat of multidrugresistant gonorrhoea in Europe","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2012"},{"key":"10.1016\/j.ijmm.2014.04.001_bib0055","series-title":"ECDC surveillance report, Gonococcal antimicrobial susceptibility surveillance in Europe, 2011","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2013"},{"key":"10.1016\/j.ijmm.2014.04.001_bib0060","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1128\/AAC.01506-09","article-title":"New mutation in 23S rRNA gene associated with high level of azithromycin resistance in Neisseria gonorrhoeae","volume":"54","author":"Galarza","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0065","doi-asserted-by":"crossref","DOI":"10.1136\/sextrans-2012-050913","article-title":"Current and future treatment options for gonorrhoea","author":"Ison","year":"2013","journal-title":"Sex Transm. Infect."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0070","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/jac\/dkl264","article-title":"Comparability of laboratory diagnosis and antimicrobial susceptibility testing of Neisseria gonorrhoeae from reference laboratories in Western Europe","volume":"58","author":"Ison","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0075","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/cid\/cir929","article-title":"Neisseria gonorrhoeae with high-level resistance to azithromycin: case report of the first isolate identified in the United States","volume":"54","author":"Katz","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0080","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/jac\/dkt034","article-title":"Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure","volume":"68","author":"Lewis","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijantimicag.2010.01.007","article-title":"Antimicrobial susceptibility of Neisseria gonorrhoeae isolates determined by the agar dilution, disk diffusion and Etest methods: comparison of results using GC agar and chocolate agar","volume":"35","author":"Liao","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijmm.2014.04.001_bib0090","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/383047","article-title":"Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area","volume":"189","author":"Martin","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0095","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1139\/cjm-2013-0357","article-title":"Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010","volume":"59","author":"Martin","year":"2013","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0100","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/AAC.46.9.3020-3025.2002","article-title":"Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae","volume":"46","author":"Ng","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0105","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/AAC.00406-09","article-title":"Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California","volume":"53","author":"Pandori","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0110","first-page":"122","article-title":"Zum Auftreten von Resistenzen bei Neisseria gonorrhoeae im Rhein-Main-Gebiet","volume":"13","author":"Rosenthal","year":"2009","journal-title":"Epidemiol. Bull.\/RKI"},{"key":"10.1016\/j.ijmm.2014.04.001_bib0115","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/BF01691501","article-title":"Epidemiology of Penicillin-resistant Neisseria gonorrhoeae in Frankfurt, Germany","volume":"14","author":"Sch\u00e4fer","year":"1995","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0120","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/AAC.01295-13","article-title":"Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010\u20132012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance","volume":"57","author":"Shimuta","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-000969","article-title":"Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing of Neisseria gonorrhoeae: a 6-year study","volume":"2","author":"Singh","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijmm.2014.04.001_bib0130","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1128\/AAC.01108-09","article-title":"Characteristics and population dynamics of mosaic penA allele-containing Neisseria gonorrhoeae isolates collected in Sydney, Australia, in 2007\u20132008","volume":"54","author":"Tapsall","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0135","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.47.19721-en","article-title":"Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010","volume":"15","author":"Unemo","year":"2010","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/CMR.00040-10","article-title":"Review and international recommendation of methods for typing Neisseria gonorrhoeae isolates and their implications for improved knowledge of gonococcal epidemiology, treatment, and biology","volume":"24","author":"Unemo","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0145","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.06.19792-en","article-title":"Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0150","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.43.19998-en","article-title":"First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011","volume":"16","author":"Unemo","year":"2011","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0155","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0160","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","article-title":"High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure","volume":"56","author":"Unemo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0165","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.47.20323-en","article-title":"The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy","volume":"17","author":"Unemo","year":"2012","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0170","first-page":"35","article-title":"Stark zunehmende Resistenz von Neisseria gonorrhoeae gegen Ciprofloxacin in Nord-deutschland","volume":"10","author":"Ungeheuer","year":"2001","journal-title":"Chemother. J."},{"key":"10.1016\/j.ijmm.2014.04.001_bib0175","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s001050051192","article-title":"Antibiotic susceptibility of Neisseria gonorrhoeae isolates in Berlin","volume":"51","author":"Wagner","year":"2000","journal-title":"Hautarzt"},{"key":"10.1016\/j.ijmm.2014.04.001_bib0180","series-title":"Sexually transmitted diseases: policies and principles for prevention and care","author":"WHO","year":"1999"},{"key":"10.1016\/j.ijmm.2014.04.001_bib0185","series-title":"Global incidence and prevalence of selected curable sexually transmitted infections \u2013 2008","isbn-type":"print","author":"WHO","year":"2012","ISBN":"http:\/\/id.crossref.org\/isbn\/9789241503839"},{"key":"10.1016\/j.ijmm.2014.04.001_bib0190","series-title":"Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae","author":"WHO","year":"2012"}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S143842211400037X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S143842211400037X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T23:39:59Z","timestamp":1648856399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S143842211400037X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":38,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S143842211400037X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2014.04.001","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2014.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}